期刊文献+

帕瑞昔布钠不同给药时机对瑞芬太尼复合麻醉患者术后急性阿片类药物耐受的影响 被引量:7

Effects of different time administration of parecoxib sodium on acute opioid tolerance after remifentanil anesthesia
原文传递
导出
摘要 目的 探讨帕瑞昔布钠不同给药时机对瑞芬太尼复合麻醉患者术后急性阿片类药物耐受的影响.方法 择期拟行胆囊切除术患者54例,ASA Ⅰ或Ⅱ级,年龄30~64岁,随机分为3组(n=18):均靶控输注异丙酚(血浆靶浓度3μg/ml)和瑞芬太尼(血浆靶浓度4 ng/m1)行麻醉诱导和维持,Ⅰ 组和Ⅱ组分别于麻醉前30 min、术毕前30 min静脉注射帕瑞昔布钠40 mg,C组为对照组.术后在麻醉复苏室30 min内每隔5 min询问患者的疼痛情况,疼痛评分〉0分时,静脉注射吗啡2 rag,30 min后连接病人自控静脉镇痛泵(按压1次吗啡剂量1-1lg,锁定时间5 min)返回病房,记录术后30 min内、30 min~24 h及24~48 h的吗啡用量,观察不良反应的发生情况.结果 与C组比较,Ⅰ组术后48 h内各时段、Ⅱ组术后30 min~24 h及24~48 h的吗啡用量降低(P〈0.05),Ⅱ组术后30 min内差异无统计学意义(P〉0.05);与Ⅰ组比较,Ⅱ组术后30 min内吗啡用量升高(P〈0.05).各组均未见不良反应发生.结论 麻醉前30 rain静脉注射帕瑞昔布钠40 mg可有效减轻瑞芬太尼复合麻醉患者术后早期的急性阿片类药物耐受. Objective To investigate the effects of different time administration of parecoxib sodium on acute opioid tolerance after remifentanil-based anesthesia in patients. Methods Fifty-four ASA Ⅰ or Ⅱ patients aged 30-64 yr undergoing transabdominal cholecystcctomy were randomly divided into 3 groups ( n = 18 each) : group Ⅰ- received parecoxib 40 mg at 30 rain before anesthesia; group Ⅱ received parecoxib 40 mg at 30 rain before termination of anesthesia; group C control. Anesthesia was induced and maintained with prepefol and remifentanil administered via TCI. The target plasma concentration of propefol was set at 3 μg/ml and that of remifentanil at 4 ng/ml. Traeheal intubation was facilitated with rocuronium 0.6 mg/kg. Muscle relaxation was maintained with intermittent iv boluses of vecuronium during operation. Pain was assessed using behavioral pain score (0 = quiet and no pain, 1 = complaining, 2 = severe pain and/or agitation). When the pain score 〉 0, the patients received iv injection of morphine and then PCIA with morphine (bolus dose 1 rag, lockout interval 5 min, no background infusion) 30 min later. Morphine consumption and side effects were recorded within 30 min, and during 30 rain-24 h and 24-48 h after operation. Results Compared with group C, the morphine consumption was significantly decreased during all the time periods within 48 h after operation in group Ⅰ and during 30 min-24 h and 24-48 h after operation in group Ⅱ( P 〈 0.05 ). The morphine consumption was significantly higher within 30 min after operation in group Ⅱ than in group Ⅰ ( P 〈 0.05 ). No obvious side effects occurred in the 3 groups. Condusion Parecoxib sodium 40 mg given before anesthesia can reduce acute opioid tolerance after remifentanil-based anesthesia in patients.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2010年第4期424-426,共3页 Chinese Journal of Anesthesiology
关键词 环加氧酶抑制药 哌啶类 镇痛药 阿片类 药物耐受性 Cyclooxygenase inhibitors Piperidines Analgesics, opioid Drug tolerance
  • 相关文献

参考文献12

  • 1Tirault M,Derrode N,Clevenot D,et al.The effect of nafopam on morphine overconsumption induced by harge-dese remifentanil during propofol anesthesia for major-abdominal surgery.Anesth Analg,2006,102(1):110-117. 被引量:1
  • 2王庚,吴新民.瑞芬太尼复合麻醉患者术后急性阿片类药物耐受的发生[J].中华麻醉学杂志,2007,27(5):389-392. 被引量:88
  • 3Guignard B,Besesrd AE,Coste C,et al.Acute opioid tolerance:intraoperative remifentanil increases postoperative pain and morphine requirement.Anesthesiology,2000,93(2):409-417. 被引量:1
  • 4Hansen EG,Duedahl TH,Romsing J,et al.Intra-operative remi-fentanil might influence pain levels in the immediate post-operative period after major abdominal surgery.Acta Aneesthesiol Scand,2005,49(10):1464-1470. 被引量:1
  • 5Reuben SS,Ekman EF,Reghunathan K,et al.The effect of cyclo-oxygenase-2 inhihitors on acute and chronic donor-site pain after spinal-fusion surgery.Reg Anesth pain Med,2006,31(1):6-13. 被引量:1
  • 6Trester A,Sittl R,Singler B,et al.Modalation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans.Anesthesiology,2006,105(5):1016-1023. 被引量:1
  • 7Koppert W,Wehrfritz A,Korher N,et al.The cyclooxygenese iso-zyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans.Pain,2004,108(1-2):148-153. 被引量:1
  • 8Buvanendran A,Kroin JS,Berger RA,et al.Upregulation of pros-taglandin E2 and interleukius in the central nervous system and peripheral tissue during and after surgery in humans.Anesthesiology,2006,104(3):403-410. 被引量:1
  • 9Reuben SS,Buvanendran A,Kroin JS,et al.Postoperative modu-latinn of central nervous system prostaglandin E2 by cyclooxygeuase inhibitors after vascular surgery.Anesthesiology,2006,104(3):411-416. 被引量:1
  • 10Apfelbaum JL,Desjardius PJ,Brown Mr,et al.Multiple-day effi-cacy of parecoxib sodium treatment in postoperative baninnectomy pain.Clin J Pnin,2008,24(9):784-792. 被引量:1

二级参考文献15

  • 1Thompson JP, Rowbotham DJ. Remifentanil: an opioid for the 21st century. Br J Anaesth,1996, 76: 341-343. 被引量:1
  • 2Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterase. Anesth Analg, 1995, 81: 619-623. 被引量:1
  • 3Yarmush J, D'Angelo R, Kirkhart B, et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology, 1997, 87: 235-243. 被引量:1
  • 4Fletcher D, Pinaud M, Scherpereel P, et al. The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg, 2000, 90: 666-671. 被引量:1
  • 5Kissin I, Lee KS, Arthur GR, et al. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth Analg, 1996, 83: 600-605. 被引量:1
  • 6Kissin I, Brown PT, Bradley EL Jr. Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology, 1991, 75: 813- 816. 被引量:1
  • 7Gardmark M, Ekblom M, Bouw R, et al. Quantification of effect delay and acute tolerance development to morphine in the rat. J Pharmacol Exp Ther, 1993, 267: 1061-1067. 被引量:1
  • 8Saito Y, Kaneko M, Kifihara Y, et al. Interaction of intrathecally infused morphine and lidocaine in rats (part Ⅱ ): effects on the development of tolerance to morphine. Anesthesiology, 1998. 89 : 1464- 1470. 被引量:1
  • 9MarshaU H, Porteous C, MeMillan I, et al. Relief of pain by infusion of morphine after operation: does tolerance develop? Br Med J (Clin Res Ed) ,1985, 291 : 19-21. 被引量:1
  • 10Jordan B, Devi LA. Molecular mechanisms of opioid receptor signal transduction. Br J Anaesth, 1998. 81: 12-19. 被引量:1

共引文献87

同被引文献58

  • 1Sanders RD,Giombini M,Ma D,et al. Dexmedetomidine exerts dose- dependent age-independent antinociception but age-dependent hypnosis in Fischer rats[J]. Anesth Analg, 2005,100 (5) : 1295 - 1302. 被引量:1
  • 2Guneli E,Karabay YNU,Apaydin S,et al. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain[J]. Pharmacol Biochem Behav,2007,88(1 ) :9-17. 被引量:1
  • 3Arain SR,Ruehlow RM,Uhrich TD,et al. The efficacy of dexmedetomi- dine versus morphine for postoperative analgesia after major inpatient surgery[J]. Anesth Analg,2004,98( 1 ):153-158. 被引量:1
  • 4Lin TF, Yeh YC, Lin FS, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia[J]. Br J Anaesth, 2009,102( 1 ) : 117-122. 被引量:1
  • 5Wills VL,Hunt DR. Pain after laparoscopic cholecystectomy[J]. Br J Surg, 2000,87 (3) : 273-284. 被引量:1
  • 6Gerlach AT,Murphy CV,Dasta JF. An updated focused review of dexmedetomidine in adults[J]. Ann Pharmacother, 2009,43 (12) : 2064-2074. 被引量:1
  • 7Koppert W,Wehrfritz A,Korber N,et al. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans[J]. Pain,2004,108(1-2) : 148-153. 被引量:1
  • 8BUCKLEY MM, BROGDEN RN. Ketorolac. A review of its pharmaeodynamie and pharmaeokinetie properties, and thera- peutic potential[J]. Drugs, 1990, 39(1) : 86-109. 被引量:1
  • 9STROM BL, BERLIN JA, KINMAN JL, et ol. Parenteral ketorolae and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study[J]. JAMA, 1996, 275 (5) : 376-382. 被引量:1
  • 10GIERSE JK, McDONALD JJ, HAUSER SD, et ol. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2-specific inhibitors[J]. J Biol Chem, 1996, 271(26): 15810-15814. 被引量:1

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部